Hepatoma Research 2024 Best Paper Awards
We are thrilled to unveil the recipients of the "Hepatoma Research 2024 Best Paper Awards" for outstanding articles published in Hepatoma Research from January 1, 2022, to December 31, 2022. The selection process for these awards was meticulously carried out by the esteemed Selection Committee of Hepatoma Research, under the leadership of our Editor-in-Chief Prof. Guangwen Cao and Executive Chief Editor Prof. Giuliano Ramadori.
Out of 41 publications throughout 2022, the Selection Committee has identified five papers as exemplary contributions to the field. These papers have been honored with one First Prize, two Second Prizes, and two Third Prizes.
First Prize:
1. Histopathology of hepatocellular carcinoma-when and what
PDF: https://f.oaecdn.com/xmlpdf/b2c03eca-0ed1-4345-9b0f-2041d9c92d36/4511_down.pdf?v=19
Cite This Article: Gisder DM, Tannapfel A, Tischoff I. Histopathology of hepatocellular carcinoma - when and what. Hepatoma Res 2022;8:4. http://dx.doi.org/10.20517/2394-5079.2021.131
Second Prize:
1. Hepatocellular carcinoma surveillance: Current practice and future directions
PDF: https://f.oaecdn.com/xmlpdf/f41fd0a0-3642-4d8b-95c5-432d03ae47cf/4614_down.pdf?v=38
Cite This Article: Ahn JC, Lee YT, Agopian VG, Zhu Y, You S, Tseng HR, Yang JD. Hepatocellular carcinoma surveillance: current practice and future directions. Hepatoma Res 2022;8:10. http://dx.doi.org/10.20517/2394-5079.2021.131
2. Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant
PDF: https://f.oaecdn.com/xmlpdf/70608cbc-7f9e-494a-b87e-152c1a1b5a7d/4557_down.pdf?v=66
Cite This Article: Anugwom CM, Leventhal TM, Debes JD. Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant. Hepatoma Res 2022;8:7. http://dx.doi.org/10.20517/2394-5079.2021.123
Third Prize:
1. Role of Locoregional Therapies in the Management of Patients with Hepatocellular Carcinoma
PDF: https://f.oaecdn.com/xmlpdf/e53e1163-347b-4b76-94c5-e6e70ad6cf5d/4598_down.pdf?v=88
Cite This Article: Kung JWC, Ng KKC. Role of locoregional therapies in the management of patients with hepatocellular carcinoma. Hepatoma Res 2022;8:17. http://dx.doi.org/10.20517/2394-5079.2021.138
2. Robotic donor hepatectomy: a niche advancement or the way forward? A perspective from the world's largest center
PDF: https://f.oaecdn.com/xmlpdf/5375ed35-ea00-4f1d-8ead-ec6cb202c8a6/4497_down.pdf?v=44
Cite This Article: Sturdevant M, Zidan A, Broering D. Robotic donor hepatectomy: a niche advancement or the way forward? A perspective from the world's largest center. Hepatoma Res 2022;8:1. http://dx.doi.org/10.20517/2394-5079.2021.111
The Editorial Office of Hepatoma Research extends its heartfelt gratitude and congratulations to the recipients for their exceptional research published in the journal. We take immense pride in showcasing such groundbreaking contributions.
Furthermore, we wholeheartedly welcome international scientists to submit their high-quality papers to Hepatoma Research. We eagerly anticipate the opportunity to disseminate more innovative ideas and cutting-edge research among our esteemed peers.
Editor: Eric Zhang
Language Editor: Catherine Yang
Production Editor: Yan Zhang
Respectfully Submitted by the Editorial Office of Hepatoma Research
